非小细胞肺癌靶向NGS panel验证数据集

用于非小细胞肺癌靶向突变检测的NGS panel多中心验证表格数据集。

NIAID Data Ecosystem
浏览 15
基因组lung cancertargeted therapynext-generation sequencing panelanchored multiplex PCRactionable mutations
Table5_Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting

基本信息

模态
基因组
大小
0.000013751 GB
许可
CC BY 4.0
创建/更新时间
2026-10-08
版本
v1

资源简介

非小细胞肺癌靶向NGS panel验证数据集

【一句话概览】

本数据集是 figshare 公开的组学数据集,收录 1 个文件、合计 13.75 KB,主题涵盖 lung cancer、targeted therapy、next-generation sequencing panel、anchored multiplex PCR、actionable mutations,可用于生物标志物发现与分子分型研究,CC BY 4.0 许可开放获取。

【数据集背景】

本数据集源站标题为《Table5_Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting.XLSX》。配套论文《Anchored multiplex PCR for targeted next-generation sequencing》发表于 Nature Medicine(2014),DOI:10.1038/nm.3729。源站首次发布:2024-03-28。

【数据内容】

源站原始描述:Lung cancer is a paradigm for a genetically driven tumor. A variety of drugs were developed targeting specific biomarkers requiring testing for tumor genetic alterations in relevant biomarkers. Different next-generation sequencing technologies are available for library generation: 1) anchored multiplex-, 2) amplicon based- and 3) hybrid capture-based-PCR. Anchored multiplex PCR-based sequencing was investigated for routine molecular testing within the national Network Genomic Medicine Lung Cance…

【数据结构与技术规格】

文件数 1 个,合计 13.75 KB。Table5_Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored mul.XLSX:application/vnd.openxmlformats-officedocument.spreadsheetml.sheet,13.75 KB。数据集 DOI:10.3389/pore.2024.1611590.s005。

【主题与分类】

源站学科分类:Pathology、Oncology and Carcinogenesis not elsewhere classified、Pathology (excl. Oral Pathology)。主题标签:lung cancer、targeted therapy、next-generation sequencing panel、anchored multiplex PCR、actionable mutations。

【适用方向】

组学数据适用于生物标志物发现与分子分型相关建模研究。

【获取与许可】

源站页面:https://frontiersin.figshare.com/articles/dataset/Table5_Development_testing_and_validation_of_a_targeted_NGS-panel_for_the_detection_of_actionable_mutations_in_lung_cancer_NSCLC_using_anchored_multiplex_PCR_technology_in_a_multicentric_setting_XLSX/25494394

使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。

规范引用:Kumbrink, Jörg; Demes, Melanie-Christin; Jeroch, Jan; Bräuninger, Andreas; Hartung, Kristin; Gerstenmaier, Uwe; et al. (2024). Table5_Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology i…

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Table5_Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored mul.XLSX" "https://ndownloader.figshare.com/files/45325339"

文件清单

  • Table5_Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored mul.XLSX(13.75 KB)

文件总体积 13.75 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Lung cancer is a paradigm for a genetically driven tumor. A variety of drugs were developed targeting specific biomarkers requiring testing for tumor genetic alterations in relevant biomarkers. Different next-generation sequencing technologies are available for library generation: 1) anchored multiplex-, 2) amplicon based- and 3) hybrid capture-based-PCR. Anchored multiplex PCR-based sequencing was investigated for routine molecular testing within the national Network Genomic Medicine Lung Cancer (nNGM). Four centers applied the anchored multiplex ArcherDX-Variantplex nNGMv2 panel to re-analyze samples pre-tested during routine diagnostics. Data analyses were performed by each center and compiled centrally according to study design. Pre-defined standards were utilized, and panel sensitivity was determined by dilution experiments. nNGMv2 panel sequencing was successful in 98.9% of the samples (N = 90). With default filter settings, all but two potential MET exon 14 skipping variants were identified at similar allele frequencies. Both MET variants were found with an adapted calling filter. Three additional variants (KEAP1, STK11, TP53) were called that were not identified in pre-testing analyses. Only total DNA amount but not a qPCR-based DNA quality score correlated with average coverage. Analysis was successful with a DNA input as low as 6.25 ng. Anchored multiplex PCR-based sequencing (nNGMv2) and a sophisticated user-friendly Archer-Analysis pipeline is a robust and specific technology to detect tumor genetic mutations for precision medicine of lung cancer patients.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/pore.2024.1611590.s005(source: https://frontiersin.figshare.com/articles/dataset/Table5_Development_testing_and_validation_of_a_targeted_NGS-panel_for_the_detection_of_actionable_mutations_in_lung_cancer_NSCLC_using_anchored_multiplex_PCR_technology_in_a_multicentric_setting_XLSX/25494394)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案